1. Academic Validation
  2. ACSL4, PUFA, and ferroptosis: new arsenal in anti-tumor immunity

ACSL4, PUFA, and ferroptosis: new arsenal in anti-tumor immunity

  • Signal Transduct Target Ther. 2022 Apr 22;7(1):128. doi: 10.1038/s41392-022-01004-z.
Boyi Gan 1
Affiliations

Affiliation

  • 1 Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. bgan@mdanderson.org.
Figures